B2THN0 AF NFT

Alanine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib6bo4pb7igphup6puvpttitd4jcke32dkidcod7dqaftwb2iw4ei/metadata.json
IPFS of structure file: 
bafybeielrks6kudlhrhrerxxej3uzwpv4loekgbufc4gyh3qwmw5asozxu/AF-B2THN0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x661f92Fc5950020C7aB410B5F5b9a3f429F49Ae5
First NFT owner address (bech32): 
genesis1vc0e9lze2qpqc745zz6ltwdr7s5lfxh9yetntg
Current NFT ID #443006 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
443006
Accession (UniProt):
B2THN0
Name::
Alanine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Eklund 17B / Type B)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2THN0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2THN0|SYA_CLOBB Alanine--tRNA ligase OS=Clostridium botulinum (strain Eklund 17B / Type B) OX=935198 GN=alaS PE=3 SV=1 MKFTKTNDLRDAYLNFFESKDHLKLESFSLVPQNDKSLLLINAGMAPLKPYFTGLQEPPKKRITTCQKCVRTGDIDNVGITSRHGTFFEMLGNFSFGDYFKKEIIPWAWEFLTGVLELPKEKLYVTIYLDDDEAYEYWTTLTDVDKSHIFRLGKEDNFWEHGAGPCGPCTEIHFSRTDEVPKNSEEFVELSDADKIIEVWNLVFTQFDGDGKGNYEKLASTNIDTGMGLERLAVVMQNKNSIFEIDTLENILKEVGNLASVKYGEDNKIDVSLRIITDHIRSITFMISDDIMPSNEGRGYVLRRLLRRAARHGKTLGIKDAFLCNLCDVVIRDCSSAYPDLEVKKEYIKKVIKIEEDKFRETLDSGMEILNNLISELKENNEKVLKGADGFKLYDTFGFPMELTKEILEDEGLSLDEDGFHEEMKEQRERARSARKTSNYMGTDVKTLDIISSEIETTFDGYENDSLIAEVKTLVNGEDFADSITEGDNAVVVTDVTPFYAEMGGQIGDTGTIYNDNFKGKILDTKKNIGGKIIHFVEAISGELKVGDKVTLEVDNARRENIKKNHTATHLLDSALVKVLGSHVHQAGSYVSADRLRFDFSHFEGVKEEELLKVEQLVNEAIMSVTPVNTTEMDLQEAKNSGAVGIFDDKYAEKVRVVCAGEYSKELCGGTHIDNTGKIGLFKIISENGIAAGTRRIEAVTGMEAYKLVNEKAELLKQISGKLKCSEKEITSKLDQQSKEMKEKEKEITILKSKFASMEINDIINSAKDVKGINIVAYALKDVDGEALRGLCEKVRDNVNNSLTLLTSSVDGKVVICAMADKEAVSKGAHCGKVIKEVATILGGGGGGRPDMAQAGGKLPEKISEALDSVYKIVETLVK